Frontlight ResearchEarly access
CompletedNo phase
Clinical Evaluation of the i-STAT TBI Test
Key facts
- Who runs it
- Abbott Point of Care
- Where
- Austin, Baltimore, Boston, Carmel, Cincinnati, Dallas, Denver, Englewood, Houston, Indianapolis, Lexington, Miami, Milwauke, Philadelphia, Pittsburgh, Richmond, Rochester, Salt Lake City, San Francisco, and Seattle, United StatesSee the 21 sites
- Trial code
- Status
- Completed
- People taking part
- 1,106 people enrolled
- Started
- 31 Jul 2020
- Ended
- 29 Nov 2023
- Type of study
- Observational
- Treatments tested
- Blood draw
- Outcome assessments
- Record updated
- 29 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Other criteria
- Acute Blood Biomarker Branch Subject Inclusion Criteria:
- 18 years of age or older
- Subject or Legally Authorized Representative (LAR) provided informed consent for the Acute Blood Biomarker Branch (waiver of consent may be acceptable, per IRB)
- Subject presented to a health care facility or emergency department with a suspected TBI resulting from an insult to the head by an external force within 12 hours of the injury
- Subject has a CT scan of the head with all sequences (bone and soft tissue) ordered as part of standard of care at the enrolling facility or are transferred to the enrolling facility with a head CT scan sent from the originating facility
- As a result of this head injury, the subject has sustained a traumatically induced physiological disruption of brain function, as manifested by at least one of the following; Any period of loss of consciousness; Any loss of memory for events immediately before or after the injury; Any alteration of mental state at the time of the injury; Focal neurological deficits that may or may not be transient; Acute Blood Biomarker Branch Subject Exclusion Criteria
- Previous enrollment in this study
- Current (on-going) enrollment in a therapeutic or interventional clinical trial (drug or device)
- Primary diagnosis at the enrolling facility of ischemic or hemorrhagic stroke
- Time of injury is unknown and cannot be estimated
- Presented with penetrating head trauma or spinal cord injury (American Spinal Injury Association [ASIA] score of C or worse) at the enrolling facility
- Standard of care head CT scan procedures not completed prior to Emergency Department (ED) discharge
- Prisoners or patients in custody
- Patients on psychiatric hold
Where in United States
- University of Texas AustinAustin, United States
- University of Maryland Medical CenterBaltimore, United States
- Massachusetts General HospitalBoston, United States
- Rehabilitation Hospital of IndianaCarmel, United States
- University of CincinnatiCincinnati, United States
- University of Texas, South WesternDallas, United States
- Denver Health and Hospital AuthorityDenver, United States
- Craig HospitalEnglewood, United States
- Baylor College of MedicineHouston, United States
- University of Texas Health Sciences Center of HoustonHouston, United States
- Indiana University School of MedicineIndianapolis, United States
- University of KentuckyLexington, United States
- University of MiamiMiami, United States
- Medical College of WisconsinMilwauke, United States
- Penn Presbyterian Medical CenterPhiladelphia, United States
- University of Pittsburgh Medical Center, Presbyterian HospitalPittsburgh, United States
- Virginia Commonwealth UniversityRichmond, United States
- University of Rochester Medical CenterRochester, United States
- University of UtahSalt Lake City, United States
- University of California San FranciscoSan Francisco, United States
- University of WashingtonSeattle, United States
About the trial
What the trial wants to find out
The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI).
Read full original descriptionShow less
Patients will be asked to provide a blood sample.
The group in the trial
- Acute Blood Biomarker Branch
Blood drawn within 12 hours or 12-24 hours following injury for i-STAT TBI Testing and in-person baseline outcome assessments.
Treatment: Blood draw and Outcome assessments
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 October 2026